I've been quietly reading all the posts.
Realistically CTO is still a production risk at the moment as it's still very much in the development phase... hence the low production targets set for the June and September quarter.
It was actually brave to come out with the short term targets because of the associated short term development/production risks.
Simply put ..
We need to get to 5-7 stopes .. with 10 - 15 operating mining faces before the risk disappears and Warrior hits its straps (sometime next year I reckon).
December quarter should be when it starts to happen, we should have probably 3 stopes producing around then ?
The management would be well aware of and I reckon has learnt from being overoptimistic in the past, production wise (but the power upgrade delay of 15 months didn't help) and so I think wants to respond in a language we all understand and want to hear- and that is gold ounces.
So less rhetoric and more ounces - and late this year/ next year we should get there .. but patience is the key.
Fingers crossed.
- Forums
- ASX - By Stock
- CTO
- an open message to citicorp
an open message to citicorp, page-3
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTO (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $4.433K | 1.108M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 11127183 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 13493272 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 11127183 | 0.003 |
8 | 10395025 | 0.002 |
9 | 14702988 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 13493272 | 22 |
0.006 | 5195133 | 8 |
0.007 | 2675523 | 4 |
0.008 | 1850000 | 4 |
0.009 | 2570800 | 5 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
CTO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online